Q301--Transplant Laboratory Testing See attached 0002 for details.

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 seeks a contractor to provide transplant reference laboratory testing services for the Michael E. DeBakey VA Medical Center in Houston, Texas, with proposals due June 12, 2026, at 1:00 p.m. CST. This is an unrestricted procurement; no set-aside applies.

The VA intends to award a firm fixed-price Indefinite Delivery Indefinite Quantity contract for five consecutive 12-month ordering periods with an optional six-month extension. The estimated total contract value is $41.5 million. Place of performance is a laboratory located within 10 miles of Houston, Texas, with 24/7 staffing and year-round availability including sample pickup from MEDVAMC.

The contractor must provide comprehensive histocompatibility testing and transplant-related immune evaluation services including HLA typing, blood typing, crossmatch testing, panel reactive antibody testing, antibody identification and titration, C1q binding assays, and chimerism testing. The contractor must maintain active approval or certification from Medicare, the College of American Pathologists, and the United Network for Organ Sharing. Turnaround time standards range from one to ten business days depending on test type.

Key requirements include 100% in-person attendance at weekly Medical Review Board meetings and monthly Quality Assurance meetings, monthly turnaround time compliance reporting, and adherence to strict HIPAA and Protected Health Information safeguards under the attached Business Associate Agreement. The contractor must submit itemized invoices monthly in arrears specifying contract number, purchase order number, CPT codes, test descriptions, quantities, and pricing. Award will be made using Lowest Priced Technically Acceptable evaluation criteria. NAICS code is 621511, Medical Laboratories; PSC is Q301. The incumbent contractor is Baylor College of Medicine under previous contract 36C25621D0050. Amendment 0001 issued May 18, 2026, and Amendment 0002 posted June 1, 2026; acknowledgment of amendments is required.